Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Toan Ong to Child

This is a "connection" page, showing publications Toan Ong has written about Child.

 
Connection Strength
 
 
 
0.217
 
  1. Lindberg DM, Peterson RA, Orsi-Hunt R, Chen PCB, Kille B, Rademacher JG, Hensen C, Listman D, Ong TC. Routine Emergency Department Screening to Decrease Subsequent Physical Abuse. Ann Emerg Med. 2024 Dec; 84(6):628-638.
    View in: PubMed
    Score: 0.052
  2. Maloney P, Reeves EL, Wielgosz K, Price AM, Natarajan K, DeSilva MB, Dascomb K, Klein NP, Tartof SY, Irving SA, Grannis SJ, Ong TC, Weber ZA, Schuster JE, Zerr DM, Michaels MG, Boom JA, Halasa NB, Staat MA, Weinberg GA, House SL, Saade EA, Geffel KM, Gaglani M, Wernli KJ, Murugan V, Martin ET, Bontrager NAB, Kirby MK, Payne AB, Dawood FS, Tannis A, Moline HL, Zhao SK, Adams K, DeCuir J, Olson SM, Chung JR, Lewis N, Flannery B, Reed C, Garg S, Ellington S. Interim Estimates of 2025-26 Seasonal Influenza Vaccine Effectiveness - United States, September 2025-February 2026. MMWR Morb Mortal Wkly Rep. 2026 Mar 12; 75(9):116-123.
    View in: PubMed
    Score: 0.015
  3. Irving SA, Rowley EAK, Chickery S, Natarajan K, Klein NP, Grannis SJ, Ong TC, Ball SW, DeSilva MB, Dascomb K, Naleway AL, Stockwell MS, Stephens AB, Zerbo O, Hansen J, Block L, Jacobson KB, Dixon BE, Rogerson C, Duszynski T, Barron MA, Mayer D, Chavez C, Weber ZA, Reese SE, Essien I, Sheffield T, Bride D, Arndorfer J, Van Otterloo J, Koppolu P, Mak J, Kautz A, DeCuir J, Wiegand RE, Payne AB, Link-Gelles R. Effectiveness of 2024-2025 COVID-19 Vaccines in Children in the United States - VISION, August 29, 2024-September 2, 2025. MMWR Morb Mortal Wkly Rep. 2025 Dec 11; 74(40):607-614.
    View in: PubMed
    Score: 0.015
  4. Tenforde MW, Reeves EL, Weber ZA, Tartof SY, Klein NP, Dascomb K, DeSilva MB, Yang DH, Grannis SJ, Irving SA, Ong TC, Link-Gelles R, Salas SB, Sy LS, Lewin B, Contreras R, Zerbo O, Fireman B, Hansen J, Timbol J, Sheffield T, Bride D, Arndorfer J, VanOtterloo J, McEvoy CE, Akinsete OO, Essien IJ, Dixon BE, Rogerson C, Fadel WF, Duszynski T, Naleway AL, Barron MA, Rao S, Mayer D, Chavez C, Ball SW, Payne AB, Ray C, Dickerson M, Neelam V, Adams K, Flannery B, DeCuir J, Garg S. Influenza Vaccine Effectiveness Against Hospitalizations and Emergency Department or Urgent Care Encounters for Children, Adolescents, and Adults During the 2023-2024 Season, United States. Clin Infect Dis. 2025 Oct 06; 81(3):667-678.
    View in: PubMed
    Score: 0.014
  5. Frutos AM, Cleary S, Reeves EL, Ahmad HM, Price AM, Self WH, Zhu Y, Safdar B, Peltan ID, Gibbs KW, Exline MC, Lauring AS, Ball SW, DeSilva M, Tartof SY, Dascomb K, Irving SA, Klein NP, Dixon BE, Ong TC, Vaughn IA, House SL, Faryar KA, Nowalk MP, Gaglani M, Wernli KJ, Murugan V, Williams OL, Selvarangan R, Weinberg GA, Staat MA, Halasa NB, Sahni LC, Michaels MG, Englund JA, Kirby MK, Surie D, Dawood FS, Clopper BR, Moline HL, Link-Gelles R, Payne AB, Harker E, Wielgosz K, Weber ZA, Yang DH, Lewis NM, DeCuir J, Olson SM, Chung JR, Flannery B, Grohskopf LA, Reed C, Garg S, Ellington S. Interim Estimates of 2024-2025 Seasonal Influenza Vaccine Effectiveness - Four Vaccine Effectiveness Networks, United States, October 2024-February 2025. MMWR Morb Mortal Wkly Rep. 2025 Feb 27; 74(6):83-90.
    View in: PubMed
    Score: 0.014
  6. Adams K, Weber ZA, Yang DH, Klein NP, DeSilva MB, Dascomb K, Irving SA, Naleway AL, Rao S, Gaglani M, Flannery B, Garg S, Kharbanda AB, Grannis SJ, Ong TC, Embi PJ, Natarajan K, Fireman B, Zerbo O, Goddard K, Timbol J, Hansen JR, Grisel N, Arndorfer J, Ball SW, Dunne MM, Kirshner L, Chung JR, Tenforde MW. Vaccine Effectiveness Against Pediatric Influenza-A-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2022-2023 Season: VISION Network. Clin Infect Dis. 2024 03 20; 78(3):746-755.
    View in: PubMed
    Score: 0.013
  7. Link-Gelles R, Ciesla AA, Rowley EAK, Klein NP, Naleway AL, Payne AB, Kharbanda A, Natarajan K, DeSilva MB, Dascomb K, Irving SA, Zerbo O, Reese SE, Wiegand RE, Najdowski M, Ong TC, Rao S, Stockwell MS, Stephens A, Goddard K, Martinez YC, Weber ZA, Fireman B, Hansen J, Timbol J, Grannis SJ, Barron MA, Embi PJ, Ball SW, Gaglani M, Grisel N, Arndorfer J, Tenforde MW, Fleming-Dutra KE. Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months-5 Years - VISION Network, United States, July 2022-June 2023. MMWR Morb Mortal Wkly Rep. 2023 Aug 18; 72(33):886-892.
    View in: PubMed
    Score: 0.012
  8. Klein NP, Demarco M, Fleming-Dutra KE, Stockwell MS, Kharbanda AB, Gaglani M, Rao S, Lewis N, Irving SA, Hartmann E, Natarajan K, Dalton AF, Zerbo O, DeSilva MB, Konatham D, Stenehjem E, Rowley EAK, Ong TC, Grannis SJ, Sloan-Aagard C, Han J, Verani JR, Raiyani C, Dascomb K, Reese SE, Barron MA, Fadel WF, Naleway AL, Nanez J, Dickerson M, Goddard K, Murthy K, Grisel N, Weber ZA, Dixon BE, Patel P, Fireman B, Arndorfer J, Valvi NR, Griggs EP, Hallowell C, Embi PJ, Ball SW, Thompson MG, Tenforde MW, Link-Gelles R. Effectiveness of BNT162b2 COVID-19 Vaccination in Children and Adolescents. Pediatrics. 2023 05 01; 151(5).
    View in: PubMed
    Score: 0.012
  9. Klein NP, Stockwell MS, Demarco M, Gaglani M, Kharbanda AB, Irving SA, Rao S, Grannis SJ, Dascomb K, Murthy K, Rowley EA, Dalton AF, DeSilva MB, Dixon BE, Natarajan K, Stenehjem E, Naleway AL, Lewis N, Ong TC, Patel P, Konatham D, Embi PJ, Reese SE, Han J, Grisel N, Goddard K, Barron MA, Dickerson M, Liao IC, Fadel WF, Yang DH, Arndorfer J, Fireman B, Griggs EP, Valvi NR, Hallowell C, Zerbo O, Reynolds S, Ferdinands J, Wondimu MH, Williams J, Bozio CH, Link-Gelles R, Azziz-Baumgartner E, Schrag SJ, Thompson MG, Verani JR. Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5-17 Years - VISION Network, 10 States, April 2021-January 2022. MMWR Morb Mortal Wkly Rep. 2022 Mar 04; 71(9):352-358.
    View in: PubMed
    Score: 0.011
  10. Tillman AR, Colborn KL, Scott KA, Davidson AJ, Khanna A, Kao D, McKenzie L, Ong T, Rausch CM, Duca LM, Daley MF, Coleman S, Costa E, Fernie E, Crume TL. Associations Between Socioeconomic Context and Congenital Heart Disease Related Outcomes in Adolescents and Adults. Am J Cardiol. 2021 01 15; 139:105-115.
    View in: PubMed
    Score: 0.010
  11. Crume TL, Duca LM, Ong T, Kraus E, Scott K, Khanna A, Kao D, Rausch CM, McKenzie L, Daley MF, Coleman S, Kahn MG, Costa E, Davidson AJ. Population-level surveillance of congenital heart defects among adolescents and adults in Colorado: Implications of record linkage. Am Heart J. 2020 08; 226:75-84.
    View in: PubMed
    Score: 0.010
  12. Jensen ET, Dabelea DA, Praveen PA, Amutha A, Hockett CW, Isom SP, Ong TC, Mohan V, D'Agostino R, Kahn MG, Hamman RF, Wadwa P, Dolan L, Lawrence JM, Madhu SV, Chhokar R, Goel K, Tandon N, Mayer-Davis E. Comparison of the incidence of diabetes in United States and Indian youth: An international harmonization of youth diabetes registries. Pediatr Diabetes. 2021 02; 22(1):8-14.
    View in: PubMed
    Score: 0.010
  13. Amutha A, Praveen PA, Hockett CW, Ong TC, Jensen ET, Isom SP, D'Agostino RBJ, Hamman RF, Mayer-Davis EJ, Wadwa RP, Lawrence JM, Pihoker C, Kahn MG, Dabelea D, Tandon N, Mohan V. Treatment regimens and glycosylated hemoglobin levels in youth with Type 1 and Type 2 diabetes: Data from SEARCH (United States) and YDR (India) registries. Pediatr Diabetes. 2021 02; 22(1):31-39.
    View in: PubMed
    Score: 0.010
  14. Praveen PA, Hockett CW, Ong TC, Amutha A, Isom SP, Jensen ET, Mohan V, Dabelea DA, D'Agostino RB, Hamman RF, Mayer-Davis EJ, Lawrence JM, Dolan LM, Kahn MG, Madhu SV, Tandon N. Diabetic ketoacidosis at diagnosis among youth with type 1 and type 2 diabetes: Results from SEARCH (United States) and YDR (India) registries. Pediatr Diabetes. 2021 02; 22(1):40-46.
    View in: PubMed
    Score: 0.010
  15. Hockett CW, Praveen PA, Ong TC, Amutha A, Isom SP, Jensen ET, D'Agostino RB, Hamman RF, Mayer-Davis EJ, Lawrence JM, Pihoker C, Kahn MG, Mohan V, Tandon N, Dabelea D. Clinical profile at diagnosis with youth-onset type 1 and type 2 diabetes in two pediatric diabetes registries: SEARCH (United States) and YDR (India). Pediatr Diabetes. 2021 02; 22(1):22-30.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)